BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4440123)

  • 1. Clinical evaluation of CEA in urine of patients with bladder carcinoma.
    Persijn JP; Korsten CB; Renaud J
    Z Klin Chem Klin Biochem; 1974 May; 12(5):232. PubMed ID: 4440123
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic value of urine cytology and urine carcinoembryonic antigen (CEA) level in the distinction between bladder cancer and urinary tract infection.
    Gajda M; Tyloch F; Jóźwicki W; Tyloch J; Sujkowska R; Skok Z
    Int J Occup Med Environ Health; 1995; 8(2):103-8. PubMed ID: 7582848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Clinical evaluation of CEA in urine of patients with bladder carcinoma.
    Korsten CB; Persijn JP; Renaud J
    Br J Cancer; 1974 Aug; 30(2):174-5. PubMed ID: 4419334
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcino-embryonic antigen activity in urine of patients with bladder carcinoma. Clinical evaluation of carcino-embryonic antigen. II.
    Korsten CB; Persijn JP; Renaud J; Houtzager-Boelens CA
    J Clin Chem Clin Biochem; 1976 Aug; 14(8):389-93. PubMed ID: 965892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Importance of serum and urine CEA determinations in the diagnosis of bladder cancer].
    Adolphs HD; Oehr P
    Helv Chir Acta; 1982 Aug; 49(3-4):307-11. PubMed ID: 7129893
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
    Rost A; Kneppenberg U; Rost P
    Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening tests for the detection of bladder cancer.
    Betkerur V; Hliang V; Baumgartner G; Rao R; Ablin RJ; Guinan PD
    Allergol Immunopathol (Madr); 1980; 8(3):169-76. PubMed ID: 7405763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurement of urine and serum CEA--a help in diagnosis and follow-up of bladder neoplasms].
    Edsmyr F; Wahren B; Zimmerman R
    Lakartidningen; 1975 Aug; 72(34):3141-2. PubMed ID: 1165691
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspects of the structure and clinical role of the carcinoembryonic antigen (CEA) and related macromolecules with particular reference to urothelial carcinoma.
    Neville AM; Nery R; Hall RR; Turberville C; Laurence DJ
    Br J Cancer Suppl; 1973 Aug; 1():198-207. PubMed ID: 4216361
    [No Abstract]   [Full Text] [Related]  

  • 10. Urine carcinoembryonic antigen levels are more useful than serum levels for early detection of Bilharzial and non-Bilharzial urinary bladder carcinoma: observations of 43 Egyptian cases.
    Saied GM; El-Metenawy WH; Elwan MS; Dessouki NR
    World J Surg Oncol; 2007 Jan; 5():4. PubMed ID: 17224047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma and urinary CEA-assay in patients with urological tumours (author's transl)].
    Hering H; Hering FJ; Weidner W
    Urologe A; 1976 Nov; 15(6):300-3. PubMed ID: 1006894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of urinary carcino-embryonic antigen estimations during the follow-up of patients with bladder carcinoma or previous bladder carcinoma. Clinical evaluation of carcino-embryonic antigen, III.
    Persijn JP; Korsten CB; Batterman JJ; Tierie AH; Renaud J
    J Clin Chem Clin Biochem; 1976 Aug; 14(8):395-9. PubMed ID: 965893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological detection of human bladder carcinoma.
    Monaco AP; Gozzo JJ; Schlesinger RM; Codish SD
    Ann Surg; 1975 Sep; 182(3):325-33. PubMed ID: 809015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of carcinoembryonic antigen in urine and in gastric secretions].
    Menduni P; Di Sciascio G; Lisanti A; Caracino A
    Minerva Med; 1983 Nov; 74(44):2671-5. PubMed ID: 6657117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of urinary CEA-like substance. An aid in management of patients with bladder carcinoma.
    Wahren B; Edsmyr F; Zimmerman R
    Cancer; 1975 Oct; 36(4):1490-5. PubMed ID: 1175143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term prognosis of bladder cancer. Evaluation with urinary CEA.
    Holmberg V; Nilsson B
    Anticancer Res; 1984; 4(3):121-2. PubMed ID: 6465848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a double-monoclonal radioimmunoassay for the measurement of carcinoembryonic antigen in the urine of patients with bladder cancer.
    Hetherington JW; Ewing R; Cooper EH
    Eur Urol; 1986; 12(4):270-3. PubMed ID: 3743597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen in serum, urine and cells of patients with bladder carcinoma.
    Wahren B; Edsmyr F
    Urol Res; 1978; 6(4):221-4. PubMed ID: 369085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary carcinoembryogenic antigen (CEA) in the diagnosis and follow-up of bladder carcinoma.
    Tailly G; Cornelissen M; Vereecken RL; Verduyn H; Devos P; De Roo M
    Br J Urol; 1983 Oct; 55(5):501-7. PubMed ID: 6626896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of carcinoembryonic antigen (CEA) in urine and plasma in patients with urinary bladder carcinoma].
    Hering H; Hering FJ; Weidner W
    Med Welt; 1976 May; 27(19):920-2. PubMed ID: 1272056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.